Greeting from the CEO
It is obvious that the accumulation of therapies and studies over the centuries has formed the cornerstone of healthcare, which is essential in our daily life and supports our precious life. The WHO World Health Statistics 2021 reported that at 84.3 Japan has the longest average lifespan.
Medical devices have for many years played a vital role in supporting healthcare professionals as they confront patients in the clinical setting. In recent years, while of course also pursuing efficacy and safety, the need for therapies that are less burdensome for patients has been increasing.
To meet these demands, we aim to contribute to society through developing, launching and selling products that reflect clinical needs, together with our partner companies.
We hope that our stakeholders will continue to give us their support.
Representative Director and CEO
Tatsuhiko Tahara
Mission
While pursuing maximum business efficiency we shall invest our resources in product development, launch and awareness campaigns in line with clinical needs.
Primarily with healthcare professionals, we shall construct a novel business model in collaboration with experts in manufacturing design, regulatory approval acquisition, selling, marketing and compliance with the aim of genuinely contributing to healthcare through the development of devices in the biliopancreatic field that offer support for patients both in Japan and overseas.
Compliance
In its handling of medical devices that impact significantly on the life of patients, our company engages in its activities in accordance with the related laws and regulations.
While promoting compliance, in self-awareness of our social responsibilities, we intend to fulfill our responsibility to the business setting together with our supportive stakeholders.
Company profile
|
Name |
J-MIT INC. |
|
Representative Director and CEO |
Tatsuhiko Tahara |
|
Establishment |
October 2020 |
|
Head office |
Kyoto |
|
Business office |
121-1 Imazu, Imazu-cho, Takashima-shi, Shiga
|
|
Description of business |
Selling and leasing of specially-controlled medical devices |
|
Products handled |
Gastrointestinal and biliopancreatic endoscopy devices
|
|
Banks of account |
Head Office Sales Department, Kyoto Chuo Shinkin Bank / Fushimi Branch, Mizuho Bank |
|
Business partner |
Yagami Seisakusho Co., Ltd. |
|
Doctors Cabinet supervisor |
Takao Itoi, MD, PhD, FJGES, FACG, FASGE, Professor and Chair Dept. of Gastroenterology and Hepatology, Tokyo Medical University |
|
Legal adviser |
Koyano Law Office |
|
Graphics designer |
Hikaru Yamamoto |
Greeting from the CEO
Representative Director and CEO
Tatsuhiko Tahara
It is obvious that the accumulation of therapies and studies over the centuries has formed the cornerstone of healthcare, which is essential in our daily life and supports our precious life. The WHO World Health Statistics 2021 reported that at 84.3 Japan has the longest average lifespan.
Medical devices have for many years played a vital role in supporting healthcare professionals as they confront patients in the clinical setting. In recent years, while of course also pursuing efficacy and safety, the need for therapies that are less burdensome for patients has been increasing.
To meet these demands, we aim to contribute to society through developing, launching and selling products that reflect clinical needs, together with our partner companies.
We hope that our stakeholders will continue to give us their support.
Mission
While pursuing maximum business efficiency we shall invest our resources in product development, launch and awareness campaigns in line with clinical needs.
Primarily with healthcare professionals, we shall construct a novel business model in collaboration with experts in manufacturing design, regulatory approval acquisition, selling, marketing and compliance with the aim of genuinely contributing to healthcare through the development of devices in the biliopancreatic field that offer support for patients both in Japan and overseas.
Compliance
In its handling of medical devices that impact significantly on the life of patients, our company engages in its activities in accordance with the related laws and regulations.
While promoting compliance, in self-awareness of our social responsibilities, we intend to fulfill our responsibility to the business setting together with our supportive stakeholders.
Company profile
|
Name |
J-MIT Co., Ltd. |
|
Representative Director and CEO |
Tatsuhiko Tahara |
|
Establishment |
October 2020 |
|
Head office |
Kyoto |
|
Business office |
121-1 Imazu, Imazu-cho, Takashima-shi, Shiga |
|
Description of business |
Selling and leasing of specially-controlled medical devices |
|
Products handled |
Gastrointestinal and biliopancreatic endoscopy devices
|
|
Banks of account |
Head Office Sales Department, Kyoto Chuo Shinkin Bank / Fushimi Branch, Mizuho Bank |
|
Business partner |
Yagami Seisakusho Co., Ltd. |
|
Doctors Cabinet supervisor |
Takao Itoi, MD, PhD, FJGES, FACG, FASGE, Professor and Chair Dept. of Gastroenterology and Hepatology, Tokyo Medical University |
|
Legal adviser |
Koyano Law Office |
|
Graphics designer |
Hikaru Yamamoto |